Welcome To ProClinical
ProClinical is a specialist Pharmaceutical R&D recruitment company. Our customised solutions cover Executive Search as well as permanent and contract recruitment. We represent many Big Pharma clients, emerging biopharmaceutical companies, leading CROs and medical device pioneers.
Equipped with the best recruitment tools available, ProClinical Consultants possess an unrivalled drive to deliver the best results possible for both our clients and our candidates, with integrity and professionalism.
Request a call back or call us on 0845 338 6223 for a consultation.
Latest news:
Sanofi buoyed as FDA approves Multaq and backs Lantus
Sanofi-Aventis has received a major boost with the news that regulators in the USA have approved its cardiovascular drug Multaq and a launch across the Atlantic will take place over the summer More...
GSK spends £23.2 million to bag B-MS products in Middle East
GlaxoSmithKline is continuing with its strategy of expanding in the emerging markets and has acquired the branded generics business of Bristol-Myers Squibb in five Middle East countries More...
FDA demands boxed warnings on Chantix and Zyban
Regulators in the USA have told Pfizer and GlaxoSmithKline to include a boxed warning on their smoking cessation products, Chantix and Zyban, about the risk of "serious mental health events” More...
Biogen MS deal with Acorda could be worth over $500 million
A day after reporting a failure in the clinic with a mid-stage multiple sclerosis compound, Biogen Idec has responded by buying certain rights to Acorda Therapeutics’ investigational MS drug Fampridine-SR More...
Eisai/Pfizer’s Alzheimer’s battle with NICE comes to an end
Pfizer and Eisai have decided they will not lodge an appeal against the National Institute for Health and Clinical Excellence’s current guidance for the treatment of Alzheimer’s disease. More...